rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1998-9-21
|
pubmed:abstractText |
To investigate the effect of the islet promoter region variant (G-->A) at nucleotide -30 of the glucokinase (GCK) gene on insulin levels in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and NIDDM.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0149-5992
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1194-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9653619-Administration, Oral,
pubmed-meshheading:9653619-Adult,
pubmed-meshheading:9653619-Aged,
pubmed-meshheading:9653619-Alleles,
pubmed-meshheading:9653619-Diabetes Mellitus, Type 2,
pubmed-meshheading:9653619-Fasting,
pubmed-meshheading:9653619-Female,
pubmed-meshheading:9653619-Finland,
pubmed-meshheading:9653619-Genes,
pubmed-meshheading:9653619-Genetic Variation,
pubmed-meshheading:9653619-Glucokinase,
pubmed-meshheading:9653619-Glucose,
pubmed-meshheading:9653619-Glucose Intolerance,
pubmed-meshheading:9653619-Glucose Tolerance Test,
pubmed-meshheading:9653619-Heterozygote,
pubmed-meshheading:9653619-Homozygote,
pubmed-meshheading:9653619-Humans,
pubmed-meshheading:9653619-Injections, Intravenous,
pubmed-meshheading:9653619-Insulin,
pubmed-meshheading:9653619-Islets of Langerhans,
pubmed-meshheading:9653619-Male,
pubmed-meshheading:9653619-Middle Aged,
pubmed-meshheading:9653619-Point Mutation,
pubmed-meshheading:9653619-Promoter Regions, Genetic
|
pubmed:year |
1998
|
pubmed:articleTitle |
Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
|
pubmed:affiliation |
Department of Medicine, University of Kuopio, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|